Cisplatin not inferior to oxaliplatin for systemic treatment of resectable GCJuly 31, 2022Gastrointestinal Cancer
Better survival in patients with MSI-high vs MSS gastric cancer despite worse chemotherapy responseJuly 31, 2022Gastrointestinal Cancer
Advanced gastric cancer: Efficacy of anti-PD-1 antibodies plus multikinase inhibitors unaffected by liver metastasisJuly 31, 2022Gastrointestinal Cancer
Beta adrenergic blockade improves the prognosis of patients with CRCJuly 31, 2022Gastrointestinal Cancer
Hepatic arterial infusion-chemotherapy with FOLFIRINOX: A feasible treatment option for metastatic CRCJuly 31, 2022Gastrointestinal Cancer
Cardiovascular disease: The leading cause of noncancer death in CRCJuly 31, 2022Gastrointestinal Cancer
CRC: Colonoscopy offers a survival benefit over fecal immunochemical testJuly 31, 2022Gastrointestinal Cancer
Cytoreductive surgery + hyperthermic intraperitoneal chemotherapy confers survival benefit in CRC peritoneal metastasisJuly 31, 2022Gastrointestinal Cancer
Efficacy of colonoscopy for preventing CRC remains unaffected by locationJuly 31, 2022Gastrointestinal Cancer
FOLFIRI-bevacizumab tops FOLFIRI-aflibercept in treating metastatic CRC after FOLFOX-bevacizumab failureJuly 31, 2022Gastrointestinal Cancer
